Novara, Italy

Enrico Dalcanale


Average Co-Inventor Count = 1.6

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 1985-1987

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Enrico Dalcanale: Innovator in Pharmaceutical Chemistry

Introduction

Enrico Dalcanale is a notable inventor based in Novara, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes for synthesizing important chemical compounds. His work has implications for the production of pharmaceutical products and veterinary drugs.

Latest Patents

Dalcanale holds 2 patents, showcasing his expertise in chemical processes. His latest patents include a process for the preparation of 2-alkyl cyclopent-2-enones. This process involves oxidizing an alpha-olefin to form an epoxide, which is then reacted with an alkylating agent to yield a gamma-alkyl lactone. This lactone is subsequently reacted with a protic acid to produce the desired 2-alkylcyclopent-2-enone, which serves as an intermediate for pharmaceutical products, particularly prostaglandins. Another patent focuses on the oxidation of aldehydes to carboxylic acids, further demonstrating his innovative approach to chemical synthesis.

Career Highlights

Dalcanale is associated with Montedison S.p.a., a company known for its advancements in chemical production. His work at Montedison has allowed him to develop processes that enhance the efficiency and effectiveness of chemical synthesis in the pharmaceutical industry.

Collaborations

Throughout his career, Dalcanale has collaborated with esteemed colleagues such as Giorgio Bottaccio and Stefano Campolmi. These collaborations have contributed to the advancement of his research and the successful development of his patented processes.

Conclusion

Enrico Dalcanale's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a significant inventor in the field. His work continues to impact the production of essential pharmaceutical compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…